Abstract:Objective Congenital heart disease (CHD) is the most common birth defect in humans. The genetic causes for CHD remain largely unknown. Tetralogy of Fallot (TOF) is one major component of conotruncal defects (CTD), a complex CHD induced by abnormal development of the outflow tract. Retinoid X receptor alpha (RXRA), a ligand-dependent transcript factor, plays a critical role in multiple aspects of cardiogenesis including the development of outflow tract (OFT). Taken together, RXRA may be a potential candidate gene of TOF. To date, RXRA gene promoter region has not been analyzed and reported in TOF patients. We hypothesized that the sequence variants within RXRA gene promoter region may change RXRA levels and the development of TOF. In this study, the promoter regions of RXRA gene were genetically analyzed.Methods Case group included DNA samples from patients with TOF, which had been confirmed by cardiac catheterization and surgery. Control group consisted of DNA samples from randomly selected healthy children. Genomic DNA was extracted from peripheral blood. PCR was used to amplify the 1 417 bp promoter region from genomic DNA. PCR products were sequenced by ABI Prism Bigdye system.Results The promoter regions of RXRA gene were genetically analyzed in 213 TOF patients and 500 healthy controls. One novel heterozygous mutation, -1 191A>AG (according to the transcription start site), was found in one TOF patients, but in none of controls. Three novel single-nucleotide polymorphisms, -1287C>CT, -800C>CA and -760C>CT were found in both TOF patients and controls. There were no statistically significant changes in the genotype and allele frequencies of the three SNPs between TOF patients and control group (P>0.05). Several transcription factor binding sites were found within the region containing these single-nucleotide variations by searching http://www.cbrc.jp/research/db/TFSEARCH.html. Conclusions The A at position -1 191 following C, and C at position -800 was followed by G, thus these single-nucleotide variations provided additional candidate cytosines (CpG) for methylation that may enhance the level of gene expression.The sequence variants within RXRA gene promoter may contribute to the TOF etiology by altering the expression levels of RXRA gene.

DNA Methylation at CpG Island Shore and RXRα Regulate NR2F2 in Heart Tissues of Tetralogy of Fallot Patients.

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Elevated methylation of the RXRA promoter region may be responsible for its downregulated expression in the myocardium of patients with TOF

CpG Site Hypomethylation at ETS1‑binding Region Regulates DLK1 Expression in Chinese Patients with Tetralogy of Fallot.

CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples

Methylation Status of CpG Sites in the NOTCH4 Promoter Region Regulates NOTCH4 Expression in Patients with Tetralogy of Fallot.

Association of Promoter Methylation Statuses of Congenital Heart Defect Candidate Genes with Tetralogy of Fallot

Mirna-940 Reduction Contributes to Human Tetralogy of Fallot Development.

DNA Methylation Status of NKX2-5, GATA4 and HAND1in Patients with Tetralogy of Fallot

Genetic analysis of the RXRA gene promoter in tetralogy of Fallot patients

Hypermethylation-mediated down-regulation of lncRNA TBX5-AS1:2 in Tetralogy of Fallot inhibits cell proliferation by reducing TBX5 expression.

LINE-1 methylation status and its association with tetralogy of fallot in infants

Promoter Methylation and Expression of the VANGL2 Gene in the Myocardium of Pediatric Patients with Tetralogy of Fallot

Association Between Mrna Levels Of Dnmt1, Dnmt3a, Dnmt3b, Mbd2 And Line-1 Methylation Status In Infants With Tetralogy Of Fallot

Fgd5-As1 Is A Hub Lncrna Cerna In Hearts With Tetralogy Of Fallot Which Regulates Congenital Heart Disease Genes Transcriptionally And Epigenetically

DNA methylation status of TBX20 in patients with tetralogy of Fallot

Identification of miRNA–mRNA–TFs Regulatory Network and Crucial Pathways Involved in Tetralogy of Fallot

Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification

The CpG Island Methylation Status Analysis in the Promoter Region of the Conotruncal Heart Malformation Candidate Gene NKX2-5

Expression of Cx43-related microRNAs in patients with tetralogy of Fallot

MicroRNA Deregulation in Right Ventricular Outflow Tract Myocardium in Nonsyndromic Tetralogy of Fallot.